Publicacións (28) Publicacións de Clotilde Costa Nogueira

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients

    Molecular and Cellular Proteomics, Vol. 21, Núm. 12

2021

  1. Liquid biopsy: A new tool for overcoming cdki resistance mechanisms in luminal metastatic breast cancer

    Journal of Personalized Medicine, Vol. 11, Núm. 5

  2. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

  3. Short‐term ex vivo culture of ctcs from advance breast cancer patients: Clinical implications

    Cancers, Vol. 13, Núm. 11

2020

  1. Analysis of a real-world cohort of metastatic breast cancer patients shows circulating tumor cell clusters (Ctc-clusters) as predictors of patient outcomes

    Cancers, Vol. 12, Núm. 5

  2. Corrigendum to “Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells” [Materials Today Chemistry 16 (2020) 100265] (Materials Today Chemistry (2020) 16, (S2468519420300252), (10.1016/j.mtchem.2020.100265))

    Materials Today Chemistry

  3. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Methodology for the Isolation and Analysis of CTCs

    Advances in Experimental Medicine and Biology (Springer), pp. 45-59

  5. Nanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells

    Materials Today Chemistry, Vol. 16

2019

  1. CTCs expression profiling for advanced breast cancer monitoring

    Cancers, Vol. 11, Núm. 12

  2. CTCs-derived xenograft development in a triple negative breast cancer case

    International Journal of Cancer, Vol. 144, Núm. 9, pp. 2254-2265

  3. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. EGFR-based immunoisolation as a recovery target for low-EpCAM CTC subpopulation

    PLoS ONE, Vol. 11, Núm. 10

2014

  1. Biosensors for the detection of circulating tumour cells

    Sensors (Switzerland), Vol. 14, Núm. 3, pp. 4856-4875

  2. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer

    Cancer Research, Vol. 74, Núm. 22, pp. 6565-6577

2013

  1. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis

    Oncogene, Vol. 32, Núm. 24, pp. 2937-2951

  2. Skin tumors Rb(eing) uncovered

    Frontiers in Oncology, Vol. 3 DEC

  3. The Rho Exchange Factors Vav2 and Vav3 Favor Skin Tumor Initiation and Promotion by Engaging Extracellular Signaling Loops

    PLoS Biology, Vol. 11, Núm. 7

2012

  1. A novel tumor suppressor network in squamous malignancies

    Scientific Reports, Vol. 2